No profile data available.
Biofrontera Inc. (BFRI) is a healthcare company in the skin treatment pharmaceuticals industry, based in Woburn, United States, with about 84 full-time employees.
It reported revenue of $41.71 million for fiscal year 2025, up 11.7% from fiscal year 2024, and net income of -$10.54 million. Its market capitalization was $14.41 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions.
Biofrontera reported $41.71 million in revenue for fiscal year 2025, up 11.7% from $37.32 million in fiscal year 2024.
$14.41 million as of October 9, 2026.
Listed companies of a similar size in the same industry (skin treatment pharmaceuticals) include Journey Medical Corporation (DERM), Fortress Biotech, Inc. (FBIO), Quoin Pharmaceuticals, Ltd. (QNRX), Azitra, Inc. (AZTR).